MedTrace Logo

Trial of Probiotics for Constipation in Parkinson's Disease

NCT03377322 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2019-10-30

No results posted yet for this study

Summary

This is a double blinded randomised placebo controlled trial to evaluate the efficacy of probiotics in the treatment of constipation in Parkinson's disease.

Conditions

  • Parkinson Disease

Interventions

DRUG

Probiotic Capsule

Probiotic - one capsule a day for four weeks

DRUG

Placebo Capsule

Placebo - one capsule a day for four weeks

Sponsors & Collaborators

  • University of Malaya

    lead OTHER

Principal Investigators

  • Ai Huey Tan, MD,FRCP · University of Malaya

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03377322 on ClinicalTrials.gov